NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
1. | Description of the Inphi acquisition |
On April 20, 2021, the Company completed the Inphi acquisition. In accordance with the terms of the Inphi Merger agreement dated as of October 29, 2020, the Company acquired all outstanding shares of common stock of Inphi for $66 per share in cash and 2.323 shares of the Company’s common stock exchanged for each share of Inphi common stock. The merger consideration paid in cash was funded with a combination of cash on hand and funds from the Company’s debt financing. In addition, upon the acquisition, Inphi’s outstanding equity awards were replaced by the Company’s equity awards with similar terms. See “Note 5 – Calculation of Merger Consideration and Purchase Price Allocation” and “Note 2 - Description of Debt Financing” for additional information.
2. | Description of the Debt Financing |
As part of the acquisition, the Company assumed $15.7 million principal amount of Inphi’s 0.75% convertible senior notes due 2021 (the “Inphi 2021 Convertible Notes”) and $506.0 million principal amount of Inphi’s 0.75% convertible senior notes due 2025 (the “Inphi 2025 Convertible Notes”, and together with the Inphi 2021 Convertible Notes, the “Inphi Convertible Notes”). However, shortly after the acquisition, substantially all of the Inphi Convertible Notes were exchanged for cash and the Company’s common stock. The related pro forma adjustments related to the conversion of the notes are described at Note 7(d).
In connection with the acquisition, the Company executed a series of financing arrangements to raise approximately $3.8 billion from December 2020 through April 2021 to fund the Inphi acquisition. In December 2020, the Company executed a debt agreement to obtain an $875.0 million 3-year term loan and an $875.0 million 5-year term loan. On April 12, 2021, the Company completed a debt offering and issued (i) $500.0 million of Senior Notes with a 5 year term due in 2026, (ii) $750.0 million of Senior Notes with a 7 year term due in 2028, and (iii) $750.0 million of Senior Notes with a 10 year term due in 2031. In addition, in conjunction with the U.S. domiciliation, the Company exchanged certain of its existing senior notes due in 2023 and 2028 that were previously issued by the Company’s former Bermuda-based parent company with like notes that are now issued by the Company’s new parent company domiciled in Delaware.
In April 2021, the Company also terminated a $2.5 billion bridge loan commitment. This bridge loan commitment was provided by the underwriting bankers at the time of the Inphi merger agreement execution in October 2020. The bridge loan was never drawn upon. The Company recognized a write-off of $11.4 million in capitalized debt issuance cost related to the termination of the bridge loan commitment during the quarter ended May 1, 2021.
See “Note 3 - Business Combinations” and “Note 5 – Debt” within the Company’s Quarterly Report on Form 10-Q for the period ended July 31, 2021, incorporated by reference into this Form 8-K for more information.
The pro forma financial information has been prepared by the Company in accordance with Article 11 of Regulation S-X. The pro forma financial information is not necessarily indicative of what the Company’s consolidated statements of operations would have been had the Inphi acquisition been completed as of the dates indicated or will be for any future periods. The pro forma financial statements do not purport to project the future results of operations of the Company following the completion of the Inphi acquisition. The pro forma financial information reflects transaction related adjustments management believes are necessary to present fairly the Company’s pro forma results of operations following the closing of the Inphi acquisition as of and for the periods indicated. The transaction related adjustments are based on currently available information and assumptions management believes are, under the circumstances and given the information available at this time, reasonable, and reflective of adjustments necessary to report the Company’s results of operations as if the Inphi acquisition was completed as of the beginning of the previous fiscal year.
The unaudited pro forma condensed combined financial information was prepared using the acquisition method of accounting in accordance with ASC 805, with MTI as the accounting acquirer, using the fair value concepts defined in ASC Topic 820, Fair Value Measurement, and based on the historical consolidated financial statements of Marvell and Inphi. Under ASC 805, all assets acquired and liabilities assumed in a business combination are recognized and measured at their assumed acquisition date fair value, while transaction costs and restructuring costs associated with the business combination are expensed as incurred. The excess of merger consideration over the fair value of assets acquired and liabilities assumed, if any, is allocated to goodwill. IPR&D is recorded at fair value as an indefinite-lived intangible asset at the assumed merger date until completion or abandonment of the associated research and development efforts. Upon completion of development, acquired IPR&D assets are considered amortizable, finite-lived assets.
The allocation of the purchase consideration for the Inphi acquisition is preliminary and may be revised with adjustment to goodwill as additional information becomes available during the measurement period from the closing date of the acquisition to finalize such preliminary estimates. Any such revisions or changes may be material. The unaudited pro forma condensed combined financial information presented is for illustrative purposes only and is not necessarily indicative of the results of operations that would have been realized if the Inphi acquisition had been completed on the dates indicated, nor is it indicative of future operating results or financial position. The unaudited pro forma condensed combined financial information does not reflect any cost savings, operating synergies or revenue enhancements that the combined company may achieve as a result of the Inphi acquisition, the costs to integrate the operations of the Company and Inphi or the costs necessary to achieve these cost savings, operating synergies and revenue enhancements.